J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

It is a fictional representation created for illustrative purposes only. The U.S. FDA has approved Johnson & Johnson's new ...

It is a fictional representation created for illustrative purposes only. The U.S. FDA approved Johnson & Johnson's Varipulse, ...